Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15
Anantha Krishnan Dhanabalan, Gopalakrishnan Sangeetha, S. Vajravijayan, et al.
Informatics in Medicine Unlocked (2020) Vol. 20, pp. 100392-100392
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors
Negar Balmeh, Samira Mahmoudi, Niloofar Mohammadi, et al.
Informatics in Medicine Unlocked (2020) Vol. 20, pp. 100407-100407
Open Access | Times Cited: 77
Molecular Docking and Dynamics Simulation Study of Hyrtios erectus Isolated Scalarane Sesterterpenes as Potential SARS-CoV-2 Dual Target Inhibitors
Sameh S. Elhady, Reda F. A. Abdelhameed, Rania T. Malatani, et al.
Biology (2021) Vol. 10, Iss. 5, pp. 389-389
Open Access | Times Cited: 50
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
Tatjana Schwarz, Kirsten Heiß, Yuvaraj Mahendran, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
Hai Trong Nguyen, Darryl Falzarano, Volker Gerdts, et al.
Journal of Virology (2021) Vol. 95, Iss. 18
Open Access | Times Cited: 40
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Kunal Nepali, Ram Lal Sharma, Sachin Sharma, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 27
Coronavirus Endoribonuclease Ensures Efficient Viral Replication and Prevents Protein Kinase R Activation
Ye Zhao, Lu Sun, Ye Zhao, et al.
Journal of Virology (2020) Vol. 95, Iss. 7
Open Access | Times Cited: 32
In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19
Reham F. Barghash, Iten M. Fawzy, Vaisali Chandrasekar, et al.
Coatings (2021) Vol. 11, Iss. 11, pp. 1273-1273
Open Access | Times Cited: 28
Plant-based bioactive molecules for targeting of endoribonuclease using steered molecular dynamic simulation approach: a highly conserved therapeutic target against variants of SARS-CoV-2
Arpana Parihar, Sayeda Samina Ahmed, Palak Sharma, et al.
Molecular Simulation (2022) Vol. 49, Iss. 12, pp. 1267-1279
Closed Access | Times Cited: 21
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations
Sumit Kumar, Yash Gupta, Samantha E. Zak, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 10, pp. 1757-1764
Open Access | Times Cited: 23
SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms of impairment on host antiviral immunity and therapeutic approaches
Mingming Wang, Yue Zhao, Juan Liu, et al.
MedComm – Future Medicine (2022) Vol. 1, Iss. 2
Open Access | Times Cited: 16
Applying polypharmacology approach for drug repurposing for SARS-CoV2
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
Journal of Chemical Sciences (2022) Vol. 134, Iss. 2
Open Access | Times Cited: 14
Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies
Sumit Kumar, Prem P. Sharma, Charu Upadhyay, et al.
Methods (2021) Vol. 195, pp. 44-56
Open Access | Times Cited: 18
Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition
Rutuja Umesh Savale, Shovonlal Bhowmick, Sameh M. Osman, et al.
Archives of Biochemistry and Biophysics (2021) Vol. 700, pp. 108771-108771
Open Access | Times Cited: 17
Druggability of Cavity Pockets Within SARS-CoV-2 Spike Glycoprotein and pharmacophore-based Drug Discovery
Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, et al.
Future Virology (2021) Vol. 16, Iss. 6, pp. 389-397
Open Access | Times Cited: 17
Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries
Yosef Masoudi-Sobhanzadeh, Aysan Salemi, Mohammad M. Pourseif, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 16
Role of Stress Granules in Suppressing Viral Replication by the Infectious Bronchitis Virus Endoribonuclease
Ye Zhao, Delan Feng, Ye Zhao, et al.
Journal of Virology (2022) Vol. 96, Iss. 12
Open Access | Times Cited: 10
Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach
Olaa Motwalli, Meshari Alazmi
Journal of Molecular Modeling (2021) Vol. 27, Iss. 6
Open Access | Times Cited: 13
A fuzzy logic-based computational method for the repurposing of drugs against COVID-19
Yosef Masoudi-Sobhanzadeh, Hosein Esmaeili, Ali Masoudi‐Nejad
Bioimpacts (2021) Vol. 12, Iss. 4, pp. 315-324
Open Access | Times Cited: 11
Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19
D. Meshach Paul, Debadrita Basu, Shubhra Ghosh Dastidar
Journal of Molecular Modeling (2021) Vol. 27, Iss. 5
Open Access | Times Cited: 10
In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)—amentoflavone as a multitarget candidate
Andrés Portilla-Martínez, Miguel Ortíz-Flores, Isabel Carrillo‐Hidalgo, et al.
Journal of Molecular Modeling (2022) Vol. 28, Iss. 12
Open Access | Times Cited: 6
Insight into novel inhibitors fromSterculia urensagainst Cholera via pharmacoinformatics and molecular dynamics simulation approaches
M. Oliur Rahman, Sheikh Sunzid Ahmed, Ali S. Alqahtani, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10022-10043
Closed Access | Times Cited: 3
Computational Chemistry to Repurposing Drugs for the Control of COVID-19
Majid Hassanzadeganroudsari, Amir Hossein Ahmadi, Niloufar Rashidi, et al.
Biologics (2021) Vol. 1, Iss. 2, pp. 111-128
Open Access | Times Cited: 8
In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2
M A. Siddiqa, D Rao, G. Suvarna, et al.
International Journal of Peptide Research and Therapeutics (2021) Vol. 27, Iss. 3, pp. 1633-1640
Open Access | Times Cited: 6
Genome sequence analysis of nsp15 from SARS-CoV-2
Niti Yashvardhini, Deepak Kumar Jha, Amit Kumar, et al.
Bioinformation (2022) Vol. 18, Iss. 4, pp. 432-437
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top